
- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 770
Nanobodies are regarded as promising strategies and tools in both targeted detection and clinical treatment fields. However, research on targeted detection and clinical treatment of Helicobacter pylori (HP) primarily focuses on peptides, single-chain antibodies (scFv), yolk antibodies, and monoclonal antibodies. Despite their high affinity, good stability, low immunogenicity, small molecular size, and ease of modification, there have been no significant reports on the development of effective nanobody drugs for targeting Helicobacter pylori.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 675
Recently, Johnson & Johnson (JNJ) announced that its developed bispecific antibody, Rybrevant (amivantamab), has received full approval from the U.S. FDA for its use in combination with chemotherapy (carboplatin and pemetrexed) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 646
Winter is the peak season for acute cardiovascular and cerebrovascular events. Cold weather can lead to elevated blood pressure and cerebral vasospasm, increasing the likelihood of cerebrovascular disease. Myocardial infarction and sudden cardiac death are also associated with cold temperatures. Studies have shown that for every 1°C decrease in temperature, the incidence of heart disease increases by approximately 2%. Traditional treatment strategies typically involve methods such as reducing fat, improving metabolism, dilating blood vessels, or clearing vascular blockages. However, these strategies still have many limitations.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 648
Diabetes, referred to as 'Xiaoke syndrome' in traditional Chinese medicine in China, has been documented in classic Chinese medical texts such as the 'Huangdi Neijing' and 'Lingshu' as early as around 400 BC. It refers to type 2 diabetes mellitus (T2DM), characterized by symptoms such as polydipsia, polyphagia, polyuria, as well as emaciation, fatigue, and sweet urine. According to traditional Chinese medicine, the pathological mechanism of 'Xiaoke syndrome' involves the dysfunction of the lungs, stomach, and kidneys, with the underlying pathology being the consumption of Yin and fluids and an excess of dryness and heat. Symptoms persist for a long time until the condition becomes uncontrollable.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 769
Nanobodies (Nbs) are single-domain antibodies composed of variable heavy-chain domains (VHHs) derived from camelids. Their unique structure and superior properties have positioned them as a research hotspot in the global biopharmaceutical field.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 595
Neurological diseases encompass a range of conditions that affect the normal functioning of the human nervous system, such as Alzheimer's disease, Parkinson's disease, and spinal cord injuries. These ailments significantly impact the quality of life and health of patients, causing profound suffering not only to those afflicted but also to their families and friends, casting enduring psychological shadows on all involved

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 567
Tumor. It's a name that still sends shivers down the spine worldwide. How to quickly detect, diagnose, and treat tumors has always been a major challenge in the medical field. With countless scientists and medical professionals continuously researching and discovering, nanobodies, as an emerging treatment strategy, have brought revolutionary changes to cancer treatment.

- Details
-
Also available in:
- Parent Category: Knowledge Base
- Hits: 586
Since the outbreak of the COVID-19 pandemic in 2020, the biopharmaceutical industry has encountered numerous challenges, marking one of the most turbulent periods in its history. The emergence and global spread of the COVID-19 pandemic have accelerated innovation and research processes within the biopharmaceutical sector.